Artificial intelligence
fromFortune
1 day agoThe AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology's limits | Fortune
AI-driven drug development faces declining venture funding and investor confidence despite prior heavy investment, clinical trials progress, and technology not being the primary cause.